机器人辅助肺叶切除术联合加速康复外科方案的结果分析
该回顾性分析纳入2017年5月1日至2021年6月1日接受机器人辅助肺叶切除术的原发性肺癌患者574例,比较加速康复外科(ERAS)方案实施前后的费用与围手术期结局。ERAS实施后,术后3天内出院回家比例显著升高(24.5% vs 9.8%,P=.001),直接和间接住院费用均值显著降低,出院阿片类药物剂量显著降低。
要点
- ERAS方案实施后,机器人辅助肺叶切除术后3天内出院回家比例从9.8%升至24.5%(P=.001)。
- ERAS方案实施后,总住院直接费用均值(P<.001)和间接费用均值(P=.018)显著降低。
- ERAS方案实施后,出院阿片类药物剂量(吗啡等效剂量)均值显著降低(P<.001)。
核心结论
- ERAS方案实施后,机器人辅助肺叶切除术患者早期出院增加、住院费用降低,出院阿片类药物处方剂量也显著降低。
研究设计与样本
- 回顾性分析纳入2017年5月1日至2021年6月1日接受机器人辅助肺叶切除术的原发性肺癌患者574例,ERAS方案于2019年10月17日实施。
- 采用倾向评分逆概率治疗加权平衡基线特征,主要结局为住院直接和间接费用均值、并发症发生率和住院时长。
主要发现
- ERAS方案实施前315例接受机器人辅助肺叶切除术,实施后259例纳入方案。
- ERAS方案实施后,术后3天内出院回家比例显著高于实施前(24.5% vs 9.8%,P=.001)。
- ERAS方案实施后,总住院经逆概率治疗加权调整的直接费用均值显著降低(P<.001)。
- ERAS方案实施后,总住院经逆概率治疗加权调整的间接费用均值显著降低(P=.018)。
- ERAS方案实施后,出院阿片类药物剂量(吗啡等效剂量)均值显著降低(P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact on cost relative to clinical efficacy of enhanced recovery after surgery (ERAS) protocols for patients who undergo robotic-assisted lobectomy is currently unknown. The objective of this study was to compare cost and perioperative outcomes of robotic-assisted lobectomy before and after implementation of an ERAS protocol. METHODS: This was a retrospective analysis of 574 patients who underwent robotic-assisted lobectomy for primary lung carcinoma from May 1, 2017 to June 1, 2021. The ERAS protocol was implemented on October 17, 2019. Inverse probability of treatment weighting of propensity scores was used to balance baseline characteristics. The primary outcomes of the study were mean direct and indirect hospital costs, complication rates, and hospital length of stay. RESULTS: Three hundred fifteen patients underwent robotic-assisted lobectomy before implementation of the ERAS protocol, and 259 patients were enrolled on the protocol. A significantly higher percentage of patients were discharged home in less than 3 days after the ERAS protocol implementation (24.5% vs 9.8%, P = .001). There were significant decreases in the inverse probability of treatment weighting-adjusted mean direct hospital costs (P < .001) and mean indirect costs (P = .018) for the total hospital stay after ERAS protocol implementation. The mean initial discharge opioid medication dose (morphine equivalent dose) was significantly lower (P < .001) after the ERAS protocol. CONCLUSIONS: Increased early discharge and decreased hospital costs were observed for robotic-assisted lobectomy after implementation of an ERAS protocol. There was also an observed significant decrease in the discharge opioid medication doses prescribed.
引用
- Merritt RE, D'Souza DM, Abdel-Rasoul M, et al. Analysis of Outcomes for Robotic-assisted Lobectomy With an Enhanced Recovery After Surgery Protocol. Ann Thorac Surg. 2022. PMID: 36075397. doi:10.1016/j.athoracsur.2022.08.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。